Lexicon Pharmaceuticals to cut workforce by 60% to focus on drug development

(Reuters) – Lexicon Pharmaceuticals said on Friday it would reduce its workforce by about 60%, effective Dec. 31, to eliminate commercial activities and focus on drug development.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shreya Biswas)